DE69133022D1 - Viral verursachte Zerstörung von Neoplastzellen - Google Patents
Viral verursachte Zerstörung von NeoplastzellenInfo
- Publication number
- DE69133022D1 DE69133022D1 DE69133022T DE69133022T DE69133022D1 DE 69133022 D1 DE69133022 D1 DE 69133022D1 DE 69133022 T DE69133022 T DE 69133022T DE 69133022 T DE69133022 T DE 69133022T DE 69133022 D1 DE69133022 D1 DE 69133022D1
- Authority
- DE
- Germany
- Prior art keywords
- neoplastic cells
- viral destruction
- viral
- destruction
- utilise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/763—Herpes virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16632—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58205790A | 1990-09-14 | 1990-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69133022D1 true DE69133022D1 (de) | 2002-07-04 |
DE69133022T2 DE69133022T2 (de) | 2003-01-02 |
Family
ID=24327661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69133022T Expired - Fee Related DE69133022T2 (de) | 1990-09-14 | 1991-09-16 | Viral verursachte Zerstörung von Neoplastzellen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0514603B1 (de) |
JP (1) | JP3386479B2 (de) |
AT (1) | ATE218063T1 (de) |
CA (1) | CA2051289C (de) |
DE (1) | DE69133022T2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801029A (en) * | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
DE69426841T2 (de) * | 1993-02-16 | 2001-09-06 | Onyx Pharma Inc | Cytopatische Viren zur Therapie und Prophylaxe der Neoplasie |
US6093700A (en) | 1995-05-11 | 2000-07-25 | Thomas Jefferson University | Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF |
DE69535288T2 (de) * | 1994-05-13 | 2007-04-05 | Thomas Jefferson University | Verfahren zur induzierung einer immunantwort mittels rekombinanten vaccinia-viren, die das gm-csf-gen exprimieren |
GB9415320D0 (en) * | 1994-07-29 | 1994-09-21 | Medical Res Council | Cancer treatment |
US6638762B1 (en) | 1994-11-28 | 2003-10-28 | Genetic Therapy, Inc. | Tissue-vectors specific replication and gene expression |
US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
IL118942A (en) * | 1995-07-27 | 2002-09-12 | American Cyanamid Co | Nonviolent viruses used as killers - tumors and vaccines |
CA2234060A1 (en) * | 1995-10-06 | 1997-04-10 | Arch Development Corporation | Methods and compositions for viral enhancement of cell killing |
US5824318A (en) * | 1996-07-24 | 1998-10-20 | American Cyanamid Company | Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
US6565831B1 (en) | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
US6110461A (en) | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
US6136307A (en) | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
US7470426B1 (en) | 1997-10-09 | 2008-12-30 | Wellstat Biologics Corporation | Treatment of neoplasms with viruses |
US20030044384A1 (en) | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
US7780962B2 (en) | 1997-10-09 | 2010-08-24 | Wellstat Biologics Corporation | Treatment of neoplasms with RNA viruses |
DE69838340T2 (de) * | 1997-10-09 | 2008-05-21 | Wellstat Biologics Corp. | Behandlung von neoplasmen mit interferonempfindlichen, klonalen viren |
US6602499B1 (en) | 1998-04-30 | 2003-08-05 | The General Hospital Corporation | Combination viral-based and gene-based therapy of tumors |
US7691370B2 (en) | 1998-10-15 | 2010-04-06 | Canji, Inc. | Selectivity replicating viral vector |
HUP0302278A3 (en) | 1999-04-15 | 2011-01-28 | Pro Virus | Treatment of neoplasms with viruses |
CA2388807C (en) | 1999-11-12 | 2013-08-06 | Matthew C. Coffey | Viruses for the treatment of cellular proliferative disorders |
AUPQ425699A0 (en) | 1999-11-25 | 1999-12-23 | University Of Newcastle Research Associates Limited, The | A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
AU2002953436A0 (en) | 2002-12-18 | 2003-01-09 | The University Of Newcastle Research Associates Limited | A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4883662A (en) * | 1984-04-10 | 1989-11-28 | Clinical Biotechnologies, Inc. | Method of increasing natural killer cell population of cancer patients |
GB8712528D0 (en) * | 1987-05-28 | 1987-07-01 | Clayton Found Res | Gene transfer |
US5585096A (en) * | 1994-06-23 | 1996-12-17 | Georgetown University | Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
-
1991
- 1991-09-13 CA CA002051289A patent/CA2051289C/en not_active Expired - Fee Related
- 1991-09-16 DE DE69133022T patent/DE69133022T2/de not_active Expired - Fee Related
- 1991-09-16 AT AT91308439T patent/ATE218063T1/de not_active IP Right Cessation
- 1991-09-16 EP EP91308439A patent/EP0514603B1/de not_active Expired - Lifetime
- 1991-09-17 JP JP23616591A patent/JP3386479B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06100458A (ja) | 1994-04-12 |
CA2051289C (en) | 2002-11-26 |
EP0514603A1 (de) | 1992-11-25 |
EP0514603B1 (de) | 2002-05-29 |
JP3386479B2 (ja) | 2003-03-17 |
CA2051289A1 (en) | 1992-03-15 |
DE69133022T2 (de) | 2003-01-02 |
ATE218063T1 (de) | 2002-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69133022D1 (de) | Viral verursachte Zerstörung von Neoplastzellen | |
DK0927150T3 (da) | Lipoxinforbindelser og deres anvendelse til behandling af celleformeringsforstyrrelser | |
ES2157109T3 (es) | Virus citopaticos para el tratamiento y la profilasis de la neoplasia. | |
DE69804106T2 (de) | Reovirus zur behandlung von neoplasmen | |
UY25263A1 (es) | 6-derivados sustitutivos del ácido micofenólico.- | |
ES2137935T3 (es) | Preparaciones farmaceuticas que contienen una anticitoquina. | |
NO922275L (no) | Aryletere, deres fremstilling og fremgangsmaate for behandling | |
MY150893A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
DE60008143D1 (de) | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen | |
DK0652957T3 (da) | Samlede viruspartikler og deres anvendelse i en vaccine imod rotaviral sygdom | |
NO953329D0 (no) | Rekombinante viruser og deres anvendelse i genterapien for behandling av öyesykdommer | |
ATE433461T1 (de) | Rana pipiens proteine und deren verwendung in der behandlung von tumoren | |
DK34990D0 (da) | Fremgangsmaade og aggregat til fokuseret ventilation | |
ES2113910T3 (es) | Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus. | |
DE3582594D1 (de) | Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen. | |
PT888114E (pt) | Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares | |
ES2062990T3 (es) | Vacunas, que contienen la proteina f del virus del sida. | |
ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
ATE70181T1 (de) | Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie. | |
DE69524388D1 (de) | 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung | |
DE69100171T2 (de) | Synergistische Kombination zur ophthalmischen Verwendung. | |
DK0661058T3 (da) | Anvendelse af bradykininantagonister til behandling af virussygdomme | |
DK0480391T3 (da) | Emulgatorfrie emulsionspolymerer, deres fremstilling og deres anvendelse i farmaceutiske præparater med forlænget frigivelse af virksomt stof | |
DK185489D0 (da) | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse | |
DE3668778D1 (de) | Vorrichtung zur laserchirurgie und insbesondere zur keratotomie der cornea (iii). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |